Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-049455
Filing Date
2017-09-25
Accepted
2017-09-25 16:02:59
Documents
1
Period of Report
2017-09-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v475738_4.html 4  
1 OWNERSHIP DOCUMENT v475738_4.xml 4 3942
  Complete submission text file 0001144204-17-049455.txt   5512
Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RIB-X PHARMACEUTICALS, INC. 300 GEORGE STREET, SUITE 301 NEW HAVEN CT 06511
Business Address
Longcor Jarrod (Reporting) CIK: 0001545565 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36598 | Film No.: 171099864